Thor Høyer

Thor Høyer is an Overlæge (Senior Consultant) at the Department of Haematology, Faculty of Medicine, Aalborg University Hospital, Aalborg University, Denmark, where he combines clinical practice with research in haematological malignancies.

His primary research interests include:

• B-cell lymphoma and chronic lymphocytic leukemia
• Molecular genetics and somatic mutations
• Targeted therapies, particularly ibrutinib
• Neurological complications in haematological cancers

Recent publications (2022-2024) showcase his focus on translational research, integrating molecular diagnostics with clinical management. Key contributions involve the study of B-cell kinetics during ibrutinib treatment, novel genetic alterations in splenic lymphoma, and atypical neurological presentations of CNS lymphoma, reflecting a commitment to advancing precision medicine in haematology.